Comparison of effects of As2O3and As 4O6on cell growth inhibition and gene expression profiles by cDNA microarray analysis in SiHa cells

Oncology Reports

Volumn 12, Issue 3, 2004, Pages 573-580

  Ahn, Woong Shick ^a   Bae, Su Mi ^b   Lee, Keun Ho ^a   Kim, Yong Wook ^a   Lee, Joon Mo ^a   Namkoong, Sung Eun ^a   Lee, Insu P ^b   Kim, Chong Kook ^c   Seo, Jeong Sun ^c   Sin, Jeong Im ^d   Kim, Yong Wan ^b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Seoul National University   (South Korea)

^d Catholic University of Daegu   (South Korea)

Author keywords

Apoptosis; Arsenic compound; cDNA microarray; Cervical cancer; Gene ontology

Indexed keywords

ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; COMPLEMENTARY DNA; DNA; DNA FRAGMENT; ORGANOARSENIC DERIVATIVE; OXIDE; RNA;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIVISION; CHEMISTRY; COMPARATIVE STUDY; DNA MICROARRAY; DNA REPAIR; DOWN REGULATION; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; METHODOLOGY; NORTHERN BLOTTING; NUCLEIC ACID HYBRIDIZATION; TIME; TUMOR CELL LINE; UPREGULATION; UTERINE CERVIX TUMOR;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ARSENICALS; BLOTTING, NORTHERN; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; DNA; DNA FRAGMENTATION; DNA REPAIR; DNA, COMPLEMENTARY; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDES; RNA; TIME FACTORS; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 7744239015     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. 3) in the treatment of acute promyelocytic leukemia (APL): II. clinical efficacy and pharmacokinetics in relapsed patients. Blood 89: 3354-3360, 1997.
2. Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti L, Corso D, Deblasio A, Gabrilove J, Scheinberg DA, Pandolfi PP and Warrell RP Jr: Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 339: 1341-1348, 1998. (Pubitemid 28509343)
3. Zhang P, Wang SY, Hu LH, Shi FD, Qiu FD, Hong RJ, Han XY, Yang HF, Song YZ, Liu YP, Zhou J and Jin ZJ: Arsenic trioxide treated 72 cases of acute promyelocytic leukemia. Chung Hua Hsueh Yeh Hsueh Tsa Chi 17: 58-70, 1996.
4. 3 induces NB4 cell apoptosis with down-regulation of Bcl-2 expression and modulation of PML-PARalpha/PML proteins. Blood 88: 1052-1061, 1996.
5. Park WH, Seol JG, Kim ES, Hyun JM, Jung CW, Lee CC, Kim BK and Lee YY: Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Cancer Res 60: 3065-3071, 2000. (Pubitemid 30395836)
6. Gurr JR, Bau DT, Liu F, Lynn S and Jan KY: Dithiothreitol enhances arsenic trioxide-induced apoptosis in NB4 cells. Mol Pharmacol 56: 102-109, 1999. (Pubitemid 29309817)
7. Zheng J, Deng YP: Lin C, Fu M, Xiao PG and Wu M: Arsenic trioxide induces apoptosis of HPV16 DNA-immortalized human cervical epithelial cells and selectively inhibits viral gene expression. Int J Cancer 82: 286-292, 1999. (Pubitemid 29293790)
8. Yih LH and Lee TC: Arsenite induces p53 accumulation through an ATM-dependent pathway in human fibroblasts. Cancer Res 60: 6346-6352, 2000.
9. St. John LS, Sauter ER, Herlyn M, Litwin S and Adler-Storthz K: Endogenous p53 gene status predicts the response of human squamous cell carcinoma to wild-type p53. Cancer Gene Ther 7: 749-756, 2000. (Pubitemid 30314059)
10. Dong JT and Luo XM: Arsenic-induced DNA-strand breaks associated with DNA-protein crosslinks in human fetal lung fibroblasts. Mutat Res 302: 97-102, 1993.
11. Schaumloffel N and Gebel T: Heterogeneity of the DNA damage provoked by antimony and arsenic. Mutagenesis 13: 281-286, 1998. (Pubitemid 28243163)
12. Simeonova PP, Wang S, Toriuma W, Kommineni V, Matheson J, Unimye N, Kayama F, Harki D, Ding M, Vallyathan V and Luster MI: Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation. Cancer Res 60: 3445-3453, 2000. (Pubitemid 30482163)
13. Buzard GS and Kasprzak KS: Possible roles of nitric oxide and redox cell signaling in metal-induced toxicity and carcinogenesis. J Environ Pathol Toxicol Oncol 19: 179-199, 2000.
14. Cullen AP, Reid R, Campion M and Lorincz AT: Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasia. J Virol 65: 606-612, 1991.
15. Lorincz AT, Temple GF, Kurman RJ, Jenson AB and Lancaster WD: Oncogenic association of specific papillomavirus types with cervical neoplasia. J Natl Cancer Inst 79: 671-677, 1987. (Pubitemid 17145694)
16. Zur Hausen H: Papillomaviruses in anogenital cancer as a model to understanding the role of viruses in human cancers. Cancer Res 49: 4677-4681, 1989.
17. Scheffner M, Munger K, Bryne JC and Howley PM: The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 88: 5523-5527, 1991. (Pubitemid 21914777)
18. Scheffner M, Werness BA, Heibregtse JM, Levine AJ and Howley PM: The E6 oncoprotein encoded by human papilloma-virus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136, 1990. (Pubitemid 120035062)
19. Werness BA, Levine AJ and Howley PM: Association of HPV type 16 and 18 E6 protein with p53. Science 248: 76-79, 1990.
20. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM and Sherlock G: Gene ontology: tool for the unification of biology. Nat Genet 25: 25-29, 2000. (Pubitemid 30257031)
21. Kihara C, Tsunoda T, Tanaka T, Yamana H, Furukawa Y, Ono K, Kitahara O, Zembutsu H, Yanagawa R, Hirata K, Takagi T and Nakamura Y: Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles. Cancer Res 61: 6474-6479, 2001. (Pubitemid 32783254)
22. Pletcher SD, MacDonald SJ, Marguerie R, Certa U, Stearns SC, Goldstein DB and Partridge L: Genome-wide transcript profiles in aging and calorically restricted Drosophila melanogaster. Curr Biol 12: 712-723, 2002. (Pubitemid 34455424)
23. Dai J, Weinberg RS, Waxman S and Jing Y: Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 93: 268-277, 1999. (Pubitemid 29019412)
24. Murgo AJ: Clinical trials of arsenic trioxide in hematologic and solid tumors: overview of the National Cancer Institute cooperative research and development studies. Oncologist 6: 22-28, 2001.
25. Ermolaeva O, Rastogi M, Pruitt KD, Schuler GD, Bittner ML, Chen Y, Simon R, Meltzer P, Trent JM and Boguski MS: Data management and analysis for gene expression arrays. Nat Genet 20: 19-23, 1998. (Pubitemid 28410337)
26. Khan J, Simon R, Bittner M, Chen Y, Leighton SB, Pohida T, Smith PD, Jiang Y, Gooden GC, Trent JM and Meltzer PS: Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res 58: 5009-5013, 1998. (Pubitemid 28521149)
27. Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, Kohn KW, Reinhold WC, Myers TG, Andrews DT, Scudiero DA, Eisen MB, Sausville EA, Pommier Y, Botstein D, Brown PO and Weinstein JN: A gene expression database for the molecular pharmacology of cancer. Nat Genet 24: 236-244, 2000. (Pubitemid 30132190)
28. Lu T, Liu J, LeCluyse EL, Zhou YS, Cheng ML and Waalkes MP: Application of cDNA microarray to the study of arsenic-induced liver diseases in the population of Guizhou, China. Toxicol Sci 59: 185-192, 2001. (Pubitemid 32117995)
29. Branton MH and Kopp JB: TGF-beta and fibrosis. Microbes Infect 1: 1349-1365, 1999.
30. Nowak RA: Fibroids: pathophysiology and current medical treatment. Baillieres Best Pract Res Clin Obstet Gynaecol 13: 223-238, 1999.
31. Metcalfe A and Streuli C: Epithelial apoptosis. Bioassays 19: 711-720, 1997. (Pubitemid 27354092)
32. Wyllie AH: Apoptosis and carcinogenesis. Eur J Cell Biol 73: 189-197, 1997.
33. Dynlacht BD: Regulation of transcription by proteins that control the cell cycle. Nature 389: 149-152, 1997.
34. Jeffrey PD, Russo AA, Polyak K, Gibbs E, Hurwitz J, Massague J and Pavletich NP: Mechanism of CDK activation revealed by the structure of a cyclin A-CDK2 complex. Nature 376: 313-320, 1995.
35. Sherr CJ: Cancer cell cycle. Science 274: 1672-1677, 1996.
36. Sudakin V, Chan GK and Yen TJ: Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. J Cell Biol 154: 925-936, 2001. (Pubitemid 34286173)
37. King RW, Jackson PK and Kirschner MW: Mitosis in transition. Cell 79: 563-571, 1994. (Pubitemid 24363800)
38. Kao H, Marto JA, Hoffmann TK, Shabanowitz J, Finkelstein SD, Whiteside TL, Hunt DF and Finn OJ: Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells. J Exp Med 194: 1313-1323, 2001. (Pubitemid 33055049)
39. Hubscher U, Nasheuer HP and Syvaoja JE: Eukaryotic DNA polymerases, a growing family. Trends Biochem Sci 25: 143-147, 2000. (Pubitemid 30122427)
40. Schub O, Rohaly G, Smith RW, Schneider A, Dehde S, Dornreiter I and Nasheuer HP: Multiple phosphorylation sites of DNA polymerase alpha-primase cooperate to regulate the initiation of DNA replication in vitro. J Biol Chem 276: 38076-38083, 2001.
41. Touroutoglou N and Pazdur R: Thymidylate synthase inhibitors. Clin Cancer Res 2: 227-243, 1996. (Pubitemid 26075633)
42. Nichols AF and Sancar A: Purification of PCNA as a nucleotide excision repair protein. Nucleic Acids Res 20: 2441-2446, 1992.
43. Katsumi S, Kobayashi N, Imoto K, Nakagawa A, Yamashina Y, Muramatsu T, Shirai T, Miyagawa S, Sugiura S, Hanaoka F, Matsunaga T, Nikaido O and Mori T: In situ visualization of ultra-violet-light-induced DNA damage repair in locally irradiated human fibroblasts. J Invest Dermatol 117: 1156-1161, 2001. (Pubitemid 34205912)